Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
They died 'doing what they loved': The stories of workers in their 80s who died on the job - 2Burger King launches 'SpongeBob' menu ahead of film's release. A look at the Bikini Bottom-inspired meal, plus what taste testers are saying.
- 3Merz visit highlights new strategic, and strained, Germany-Israel bond
- 4Iranian rockets hit Tel Aviv area, injuring six
- 5Why More Couples Are Choosing Africa For Their Honeymoon
- Why ordering takeout or calling the dog walker might lead to a happier relationship
- vote in favor of Your #1 kind of climate
- We analyzed Philly street scenes and identified signs of gentrification using machine learning trained on longtime residents’ observations
- Lily Allen 2026 'West End Girl' Tour: How to get tickets, prices, presale info and more
- Astronomers may have spotted the 1st known 'superkilonova' double star explosion
- 9 African migrants died in freezing temperatures near Morocco-Algeria border
- The most effective method to Augment Benefits in Gold Speculation: Systems and Tips
- Figure out How to Pick the Right Toothbrush for You
- Florence's Uffizi Gallery moves treasures to safety after cyberattack
